Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor

J. A. Bridge, M. Kanamori, Z. Ma, D. Pickering, D. A. Hill, W. Lydiatt, M. Y. Lui, G. W B Colleoni, C. R. Antonescu, M. Ladanyi, S. W. Morris

Research output: Contribution to journalArticle

253 Citations (Scopus)

Abstract

Inflammatory myofibroblastic tumor (IMT) is a rare, but distinctive mesenchymal neoplasm composed of fascicles of bland myofibroblasts admixed with a prominent inflammatory component. Genetic studies of IMTs have demonstrated chromosomal abnormalities of 2p23 and rearrangement of the anaplastic lymphoma kinase (ALK) gene locus. In a subset of IMTs, the ALK C-terminal kinase domain is fused with a tropomyosin N-terminal coiled-coil domain. In the current study, fusion of ALK with the clathrin heavy chain (CTLC) gene localized to 17q23 was detected in two cases of IMT. One of these cases exhibited a 2;17 translocation in addition to other karyotypic anomalies [46, XX, t(2;17)(p23;q23), add(16)(q24)].

Original languageEnglish (US)
Pages (from-to)411-415
Number of pages5
JournalAmerican Journal of Pathology
Volume159
Issue number2
DOIs
StatePublished - Jan 1 2001

Fingerprint

Clathrin Heavy Chains
Genes
Neoplasms
Tropomyosin
Myofibroblasts
Chromosome Aberrations
Phosphotransferases
anaplastic lymphoma kinase

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Bridge, J. A., Kanamori, M., Ma, Z., Pickering, D., Hill, D. A., Lydiatt, W., ... Morris, S. W. (2001). Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. American Journal of Pathology, 159(2), 411-415. https://doi.org/10.1016/S0002-9440(10)61711-7

Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. / Bridge, J. A.; Kanamori, M.; Ma, Z.; Pickering, D.; Hill, D. A.; Lydiatt, W.; Lui, M. Y.; Colleoni, G. W B; Antonescu, C. R.; Ladanyi, M.; Morris, S. W.

In: American Journal of Pathology, Vol. 159, No. 2, 01.01.2001, p. 411-415.

Research output: Contribution to journalArticle

Bridge, JA, Kanamori, M, Ma, Z, Pickering, D, Hill, DA, Lydiatt, W, Lui, MY, Colleoni, GWB, Antonescu, CR, Ladanyi, M & Morris, SW 2001, 'Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor', American Journal of Pathology, vol. 159, no. 2, pp. 411-415. https://doi.org/10.1016/S0002-9440(10)61711-7
Bridge, J. A. ; Kanamori, M. ; Ma, Z. ; Pickering, D. ; Hill, D. A. ; Lydiatt, W. ; Lui, M. Y. ; Colleoni, G. W B ; Antonescu, C. R. ; Ladanyi, M. ; Morris, S. W. / Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. In: American Journal of Pathology. 2001 ; Vol. 159, No. 2. pp. 411-415.
@article{dcacf457d0c44698a8d3f8363c53c20b,
title = "Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor",
abstract = "Inflammatory myofibroblastic tumor (IMT) is a rare, but distinctive mesenchymal neoplasm composed of fascicles of bland myofibroblasts admixed with a prominent inflammatory component. Genetic studies of IMTs have demonstrated chromosomal abnormalities of 2p23 and rearrangement of the anaplastic lymphoma kinase (ALK) gene locus. In a subset of IMTs, the ALK C-terminal kinase domain is fused with a tropomyosin N-terminal coiled-coil domain. In the current study, fusion of ALK with the clathrin heavy chain (CTLC) gene localized to 17q23 was detected in two cases of IMT. One of these cases exhibited a 2;17 translocation in addition to other karyotypic anomalies [46, XX, t(2;17)(p23;q23), add(16)(q24)].",
author = "Bridge, {J. A.} and M. Kanamori and Z. Ma and D. Pickering and Hill, {D. A.} and W. Lydiatt and Lui, {M. Y.} and Colleoni, {G. W B} and Antonescu, {C. R.} and M. Ladanyi and Morris, {S. W.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1016/S0002-9440(10)61711-7",
language = "English (US)",
volume = "159",
pages = "411--415",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor

AU - Bridge, J. A.

AU - Kanamori, M.

AU - Ma, Z.

AU - Pickering, D.

AU - Hill, D. A.

AU - Lydiatt, W.

AU - Lui, M. Y.

AU - Colleoni, G. W B

AU - Antonescu, C. R.

AU - Ladanyi, M.

AU - Morris, S. W.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Inflammatory myofibroblastic tumor (IMT) is a rare, but distinctive mesenchymal neoplasm composed of fascicles of bland myofibroblasts admixed with a prominent inflammatory component. Genetic studies of IMTs have demonstrated chromosomal abnormalities of 2p23 and rearrangement of the anaplastic lymphoma kinase (ALK) gene locus. In a subset of IMTs, the ALK C-terminal kinase domain is fused with a tropomyosin N-terminal coiled-coil domain. In the current study, fusion of ALK with the clathrin heavy chain (CTLC) gene localized to 17q23 was detected in two cases of IMT. One of these cases exhibited a 2;17 translocation in addition to other karyotypic anomalies [46, XX, t(2;17)(p23;q23), add(16)(q24)].

AB - Inflammatory myofibroblastic tumor (IMT) is a rare, but distinctive mesenchymal neoplasm composed of fascicles of bland myofibroblasts admixed with a prominent inflammatory component. Genetic studies of IMTs have demonstrated chromosomal abnormalities of 2p23 and rearrangement of the anaplastic lymphoma kinase (ALK) gene locus. In a subset of IMTs, the ALK C-terminal kinase domain is fused with a tropomyosin N-terminal coiled-coil domain. In the current study, fusion of ALK with the clathrin heavy chain (CTLC) gene localized to 17q23 was detected in two cases of IMT. One of these cases exhibited a 2;17 translocation in addition to other karyotypic anomalies [46, XX, t(2;17)(p23;q23), add(16)(q24)].

UR - http://www.scopus.com/inward/record.url?scp=0034879895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034879895&partnerID=8YFLogxK

U2 - 10.1016/S0002-9440(10)61711-7

DO - 10.1016/S0002-9440(10)61711-7

M3 - Article

C2 - 11485898

AN - SCOPUS:0034879895

VL - 159

SP - 411

EP - 415

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 2

ER -